A unique and rare presentation of Henoch-Schonlein purpura: a case report
DOI:
https://doi.org/10.18203/2349-3291.ijcp20242746Keywords:
HSP, IgA vasculitis, Pediatric vasculitis, Gastrointestinal symptoms, Urticaria, Palpable purpuraAbstract
Henoch-Schönlein purpura (HSP), or IgA vasculitis, is a common small vessel vasculitis in children, typically presenting with palpable purpura, abdominal pain, arthritis, and renal involvement. However, atypical presentations can delay diagnosis and management. A 12-year-old girl presented with multiple episodes of loose stools and abdominal pain. The initial diagnosis focused on acute gastroenteritis, and she was treated symptomatically. Subsequently, she developed urticarial rashes with breathing difficulty, complicating the diagnosis. Despite symptomatic treatment, she experienced severe abdominal pain, hematemesis and melena. Further investigations revealed antral gastritis, duodenitis, and cystitis. On the 14th day of admission, the patient developed characteristic palpable purpura on the lower limbs. Skin biopsy confirmed leukocytoclastic vasculitis with IgA deposits, consistent with HSP. The patient recovered with supportive care and remained symptom-free on follow-up. This case underscores the importance of considering HSP in pediatric patients with atypical presentations, such as gastrointestinal symptoms and urticaria without initial purpura. Early recognition and appropriate management are essential to prevent complications and ensure favourable outcomes. The variability in HSP presentations necessitates a high index of suspicion for timely diagnosis and treatment.
References
Trnka P. Henoch-Schönlein purpura in children. J Paediatr Child Health. 2013;49(12):995-1003.
Bluman J, Goldman RD. Henoch-Schönlein purpura in children: limited benefit of corticosteroids. Can Fam Physician. 2014;60(11):1007-10.
Bista S, Adhikari Y, Karmacharya S, Joshi S, Pandey S, Adhikari N. Henoch-Schönlein purpura with antecedent allergic diseases in a 4-year-old child: a case report. Ann Med Surg (Lond). 2023;85(6):3066-9.
Dhaliwal KK, Lile NA, Tan CL, Lim CH. Life-threatening complications of Henoch-Schönlein purpura: diffuse alveolar haemorrhage, venous thrombosis and bowel ischaemia. BMJ Case Rep. 2020;13(9):e235905.
Pillebout E, Thervet E, Hill G, Corinne A, Philippe V, Dominique N. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002;13(5):1271-8.
Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore). 1999;78(6):395-409.
Trapani S, Micheli A, Grisolia F, Massimo R, Elena C, Fernanda F, et al. Henoch-Schönlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of the literature. Semin Arthritis Rheum. 2005;35(3):143-53.
Jauhola O, Ronkainen J, Koskimies O, Marja AH, Pekka A, Tuula H, et al. Clinical course of extrarenal symptoms in Henoch-Schönlein purpura: a 6-month prospective study. Arch Dis Child. 2010;95(11):871-6.
Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP. Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Nephrol Dial Transplant. 1997;12(11):2277-83.
Narchi H. Risk of long-term renal impairment and duration of follow-up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child. 2005;90(9):916-20.
